Laboratory Co. of America Holdings (NYSE:LH) Shares Acquired by Cerity Partners LLC

Cerity Partners LLC increased its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 4.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 85,156 shares of the medical research company's stock after purchasing an additional 3,462 shares during the period. Cerity Partners LLC owned 0.10% of Laboratory Co. of America worth $19,491,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Graney & King LLC acquired a new stake in Laboratory Co. of America during the 4th quarter worth approximately $26,000. Fortitude Family Office LLC boosted its holdings in shares of Laboratory Co. of America by 312.5% in the fourth quarter. Fortitude Family Office LLC now owns 132 shares of the medical research company's stock valued at $30,000 after acquiring an additional 100 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in shares of Laboratory Co. of America by 309.8% during the fourth quarter. Geneos Wealth Management Inc. now owns 168 shares of the medical research company's stock worth $39,000 after acquiring an additional 127 shares during the period. Human Investing LLC acquired a new stake in Laboratory Co. of America in the fourth quarter valued at about $39,000. Finally, Heck Capital Advisors LLC acquired a new position in Laboratory Co. of America during the 4th quarter worth approximately $44,000. 95.94% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Laboratory Co. of America

In other news, CEO Adam H. Schechter sold 6,121 shares of the firm's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $244.62, for a total value of $1,497,319.02. Following the completion of the transaction, the chief executive officer now owns 86,445 shares in the company, valued at $21,146,175.90. This trade represents a 6.61 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Mark S. Schroeder sold 5,339 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $249.23, for a total transaction of $1,330,638.97. Following the sale, the chief operating officer now owns 4,960 shares in the company, valued at approximately $1,236,180.80. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,258 shares of company stock worth $3,518,177. 0.85% of the stock is owned by company insiders.

Remove Ads

Laboratory Co. of America Stock Performance

NYSE:LH traded up $6.00 on Monday, hitting $227.46. The company's stock had a trading volume of 129,799 shares, compared to its average volume of 636,025. Laboratory Co. of America Holdings has a one year low of $191.97 and a one year high of $258.59. The stock has a fifty day moving average of $240.04 and a two-hundred day moving average of $234.91. The company has a current ratio of 1.44, a quick ratio of 1.30 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $19.03 billion, a P/E ratio of 25.79, a price-to-earnings-growth ratio of 1.71 and a beta of 0.99.

Laboratory Co. of America (NYSE:LH - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The medical research company reported $3.45 earnings per share for the quarter, beating analysts' consensus estimates of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. Research analysts predict that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current year.

Laboratory Co. of America Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Thursday, May 29th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 1.27%. Laboratory Co. of America's payout ratio is 32.65%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Morgan Stanley increased their price objective on Laboratory Co. of America from $260.00 to $270.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. Truist Financial dropped their price target on Laboratory Co. of America from $285.00 to $274.00 and set a "buy" rating for the company in a research report on Friday. UBS Group decreased their target price on shares of Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating on the stock in a research report on Tuesday, January 28th. Jefferies Financial Group increased their price objective on shares of Laboratory Co. of America from $275.00 to $290.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, Piper Sandler upped their price target on Laboratory Co. of America from $240.00 to $260.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Three research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Laboratory Co. of America has a consensus rating of "Moderate Buy" and a consensus price target of $268.77.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.